Ultra-High b Radial Diffusion MRI for Axonal Integrity Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a non-invasive biomarker for quantitative evaluation of spinal cord or optic nerve integrity, particularly for early detection of pathologic changes and monitoring drug treatment in conditions like Multiple Sclerosis and cervical spondylotic myelopathy, as existing imaging techniques are invasive or insufficiently sensitive.
Innovation Solution
The use of an MRI system to obtain ultra-high b radial diffusion-weighted imaging signals from specific nervous system regions, applying a high b-value diffusion-weighting gradient perpendicular to axonal fibers to suppress signals from hindered regions, allowing for the comparison of imaging signals indicative of axonal integrity and demyelination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional MRI imaging techniques are used, then the imaging is non-invasive, but the sensitivity for detecting pathologic changes in spinal cord or optic nerve is insufficient
Solution Approach 1:
The patent applies parameter changes by utilizing ultra-high b-value diffusion-weighting gradients (b > 3000 s/mm²) perpendicular to axonal fiber direction. This parameter change enables selective suppression of signals from hindered extra-axonal regions while preserving signals from restricted intra-axonal spaces, thereby achieving sensitive detection of axonal integrity and demyelination without increasing procedural complexity
Solution Approach 2:
The patent segments the imaging signal into two distinct components: restricted intra-axonal signals and hindered extra-axonal signals. By applying ultra-high b-value diffusion-weighting perpendicular to axonal fibers, the method separates these signal sources, allowing independent evaluation of axonal integrity (restricted diffusion) and myelin status (hindered diffusion), thus improving detection sensitivity for specific pathologic changes
2Loss of information
If existing imaging methods are used, then the procedures are simple, but they cannot provide quantitative biomarkers for axonal loss and demyelination
Solution Approach 1:
The patent introduces diffusion-weighting gradients as an intermediary mechanism that mediates between the MRI system and the neural tissue. By applying ultra-high b-value gradients perpendicular to axonal fibers, the system generates differentiated signal responses from intra- and extra-axonal spaces, enabling quantitative assessment of axonal integrity and demyelination without requiring complex additional imaging systems
Solution Approach 2:
The patent changes the diffusion-weighting parameter (b-value) to ultra-high levels (> 3000 s/mm²) and applies the gradient perpendicular to axonal fiber direction. This parameter change creates distinct signal characteristics from restricted intra-axonal water and hindered extra-axonal water, providing quantitative biomarkers for axonal loss and demyelination while maintaining a standard MRI system configuration
3Measurement precision
If ultra-high b-value diffusion-weighting gradient is applied, then signals from hindered region are suppressed, but the imaging requires high gradient strength
Solution Approach 1:
The patent changes the orientation parameter of the diffusion-weighting gradient from parallel to perpendicular relative to axonal fiber direction. This orientation change, combined with ultra-high b-values, maximizes signal suppression from hindered extra-axonal regions while preserving restricted intra-axonal signals, achieving high signal specificity without requiring excessively high gradient strengths beyond standard MRI system capabilities
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables non-invasive, quantitative evaluation of spinal cord and optic nerve integrity, effectively detecting pathologic changes and monitoring treatment efficacy by isolating signals from restricted intra-axonal spaces and hindered extra-axonal spaces, providing biomarkers for demyelination and axonal damage.
Implementation Method 1
The MRI system can apply a high b-value diffusion-weighting gradient perpendicular to an axonal fiber direction of the bundle of axons. The ultra-high b value diffusion-weighting gradient is sufficient to suppress signals from the hindered region such that the obtained radial diffusion-weighted signals are indicative of the signal from the restricted region.
Data Source
AI summary
Ultra-high b radial diffusion-weighted imaging signals can be obtained from a selected portion of a nervous system of a subject. At least two ultra-high b radial diffusion-weighted imaging signals for the selected portion of the nervous system of the subject can be compared. The comparison is indicative of changes in the integrity or intactness of a bundle of axons within the selected portion of the nervous system of the subject.